[HTML][HTML] The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms

JD Khoury, E Solary, O Abla, Y Akkari, R Alaggio… - leukemia, 2022 - nature.com
The upcoming 5th edition of the World Health Organization (WHO) Classification of
Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers …

The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee

E Campo, ES Jaffe, JR Cook… - Blood, The Journal …, 2022 - ashpublications.org
Since the publication of the Revised European-American Classification of Lymphoid
Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have …

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

PG Kemps, J Picarsic, BH Durham… - Blood, The Journal …, 2022 - ashpublications.org
ALK-positive histiocytosis is a rare subtype of histiocytic neoplasm first described in 2008 in
3 infants with multisystemic disease involving the liver and hematopoietic system. This entity …

Cutaneous histiocytoses in children

S Fraitag, JF Emile - Histopathology, 2022 - Wiley Online Library
Cutaneous histiocytoses constitute a heterogeneous group of diseases characterised by the
cutaneous accumulation of cells with the cytological and phenotypic features of …

Molecular and clinicopathologic characterization of pediatric histiocytoses

Z Hélias‐Rodzewicz, J Donadieu… - American journal of …, 2023 - Wiley Online Library
The spectrum of somatic mutations in pediatric histiocytoses and their clinical implications
are not fully characterized, especially for non‐Langerhans cell histiocytosis (‐LCH) …

[HTML][HTML] Immunopathology of tumefactive demyelinating lesions-from idiopathic to drug-related cases

AG Vakrakou, ME Brinia, I Svolaki, T Argyrakos… - Frontiers in …, 2022 - frontiersin.org
Tumefactive demyelinating lesions (TDL) represent a diagnostic dilemma for clinicians, and
in rare atypical cases a collaboration of a neuroradiologist, a neurologist, and a …

Prevalence, patterns and outcomes of cardiac involvement in Erdheim–Chester disease

LD Azoulay, M Bravetti, F Cohen-Aubart… - European Heart …, 2023 - academic.oup.com
Abstract Aims Cardiac involvement of Erdheim–Chester disease (ECD), a rare L group
histiocytosis, has been reported to be associated with poor outcomes, but systematic studies …

Orbital histiocytosis and fibrohistiocytosis: the clinicopathological characteristics of 117 patients, over a decade of experience

MT Rajabi, FA Amoli, L Koochakzadeh… - International …, 2023 - Springer
Purpose To describe the clinicopathological features of a large cohort of patients with orbital
histiocytoses and fibrohistiocytosis, such as Langerhans cell histiocytosis (LCH) and non …

[HTML][HTML] Clinical and therapeutic implications of BRAF fusions in histiocytic disorders

S Zanwar, JP Abeykoon, S Dasari, A Ravindran… - Blood cancer …, 2022 - nature.com
Histiocytic disorders represent a collection of hematologic diseases with varied clinical
presentations [1]. The identification of an oncogenic driver has enabled the classification of …

Carveol alleviates osteoarthritis progression by acting on synovial macrophage polarization transformation: An in vitro and in vivo study

S Chen, H Xu, Y He, C Meng, Y Fan, Y Qu… - Chemico-Biological …, 2024 - Elsevier
Osteoarthritis (OA) is a heterogeneous disease that affects the entire joint. Its pathogenesis
involves hypertrophy and hyperplasia of synovial cells and polarization infiltration of …